IstariISTARIStrategyB2BGet in touch

The long version

The whole story,
with the receipts.

You’ve seen the model. Here’s everything underneath it — the human stakes, how Canada compares with peer systems, and each fix explained with its evidence and its honest trade-offs.

① The human scale② The diagnosis③ The proven fixes④ The hard questions

① The human scale

It’s a statistic until it’s someone you love.

Picture someone you’d run into a burning building for. Now picture them handed a referral and a date most of a year out. The story below is an illustration built from typical wait-time data — not one real person — to show what a median wait feels like from the inside.

ILLUSTRATIVE · not a real patient
“David”, 58 — and the people who’d feel it
  1. WEEK 0Chest pain on the stairs. His family doctor — and he’s lucky to have one — refers him to a cardiologist.
  2. WEEK 11First specialist appointment. He needs a diagnostic scan; the median MRI wait alone now runs 18 weeks.
  3. WEEK 19Imaging confirms a blockage. He joins the surgical list. They call it “elective.”
  4. WEEK 27Still waiting. His daughter drives him everywhere; his work goes part-time. Waiting costs households up to $10,266/yr in lost income.
  5. WEEK ~29Around here, the median patient finally gets care. Every extra week was avoidable risk.

“Elective” doesn’t mean optional. It means you wait — and hope nothing happens while you do.

David isn’t unlucky — he’s median. Half of patients wait even longer. And the hopeful part is that nothing in his story was an accident: every delay is a designed output of how we fund, schedule, and staff care. Designed things can be redesigned.

These aren’t hypotheticals. The source reporting documents real Canadians who died while waiting — at least 23,746 in a single year, and more than 100,000 since 2018. Because several provinces report incomplete data, the true figure is almost certainly higher. And the wait is rarely a choice: only about 1 in 6 patients are waiting voluntarily, while 4 in 10 say they’d take an opening within a week.

Multiply David by 1.4 million — the procedures in the queue right now — and the human scale becomes a national one: roughly 1 in every 30 Canadians waiting for care on any given day.

② The diagnosis

We’re not underspending. We’re under-flowing.

In 2024–25 Canada spent a record $244 billion on public health care — about $5,943 per person, among the highest in the world. Yet we have fewer doctors, hospital beds, and MRI machines per capita than many peer systems, and rank near the bottom of comparable countries on getting care on time. When you spend the most and wait the longest, the problem isn’t the budget — it’s the flow.

Typical wait for a routine specialist / elective procedure — Canada vs. peer public systems
Netherlands public
shorter
Germany public
shorter
Australia ABF
shorter
Sweden ABF
shorter
Canada global budgets
28.6w

Bars are a directional comparison, not identical metrics — countries measure waits differently. Anchored on Canada’s verified 28.6-week median. “ABF” = activity-based funding.

And the national median hides a lottery. Where you live can mean a 3× difference in how long you wait — and every province is far worse than it was in 1993.

So where does the time go? No single villain — but the delay isn’t spread evenly. A handful of bottlenecks generate most of the wait, which is exactly why targeted reform works. The weighting below is a directional read of the evidence — a way to rank where effort pays off, not a precise decomposition.

Funding rewards inputs, not finished care
~⅓
Separate, un-pooled waiting lists
Operating rooms & scanners idle off-peak
~⅕
Too few staff & rules on who can do what
~⅙
Everything else (admin, data, demand spikes)
rest

Directional weighting, not a measured statistic. Ranks these from the published literature on where delay accumulates; treat the bars as “biggest levers first,” not exact shares.

③ The proven fixes

No silver bullet. A stack of fixes.

Other public systems — not private American ones — already cut their waits. So did one Canadian province. Tap any fix for how it works, the evidence, and the honest catch.

The simplest way to picture it

A waiting list is a traffic jam. No single change clears rush hour — but open a lane, add an on-ramp, retime the lights, and the jam dissolves. Each fix below is one of those moves: modest alone, decisive when stacked.

FIX 01

Single-entry referral (one shared list)

One shared queue and the next available qualified surgeon — instead of a separate list per doctor.
Quick win

Today each specialist keeps their own list. You might sit nine months behind a popular surgeon while an equally qualified colleague has a three-week gap — and nothing connects the two.

Single-entry referral pools them: you're offered the next available qualified surgeon, like one bank line feeding many tellers. Alberta's hip-and-knee pilots showed how sharply this cuts the variation.

Why it worksCheap, fast, politically gentle — it mostly removes the luck of which list you landed on.
The honest riskPatients may lose choice of a specific surgeon; depends on clean shared data and provider buy-in.
Difficulty: Quick winTime to impact: <1–2 yrsEvidence: Alberta hip & knee
FIX 02

Expanded scope of practice

Let nurse practitioners, pharmacists and PAs work to the full top of their training.
Quick win

A lot of care that waits for a physician can be safely delivered by other trained clinicians — pharmacists prescribing for minor ailments, nurse practitioners managing routine follow-ups and ordering tests.

This widens the front door without training a single new doctor, which takes a decade.

Why it worksFast and cheap; relieves the primary-care choke point that gates everything downstream.
The honest riskMeets professional turf resistance; needs clear protocols so quality and continuity hold up.
Difficulty: Quick winTime to impact: <1–2 yrsEvidence: Many OECD systems
FIX 03

Digital triage & e-consults

Nurse-led phone/video lines and doctor-to-doctor eConsults that route patients to the right care.
Quick win

"Digital triage" is broader than a chatbot: nurse-led phone and video lines, symptom-checkers, and eConsult services where a family doctor gets a specialist's written advice in days instead of a months-long referral.

A large share of eConsults resolve the question without any specialist visit — taking low-acuity cases off the queue entirely.

Why it worksCheap and fast to deploy; deflects low-acuity cases off the specialist queue.
The honest riskModest on its own; a digital divide can leave older or rural patients behind if phone options aren't kept.
Difficulty: Quick winTime to impact: <1 yrEvidence: eConsult (ON/BC) · 811 lines
FIX 04

More scanners, longer hours

More MRI/CT machines and extended hours — imaging gates the whole pathway.
Moderate

You can't treat what you haven't diagnosed. The median MRI wait is now 18.1 weeks and CT 8.8 weeks, and Canada sits below peers on scanners per capita.

Adding machines — and cheaply, running existing ones into evenings and weekends — unblocks a gate every downstream surgery waits behind.

Why it worksHigh leverage: clearing the imaging gate speeds the entire pathway.
The honest riskCapital-intensive; without referral guidelines, more scanners can mean more low-value scanning.
Difficulty: ModerateTime to impact: 1–2 yrsEvidence: Fraser 2025 · OECD
FIX 05

Specialist high-volume centres

Specialist "focused factories" that do one procedure at scale — and get very good at it.
Moderate

When a team does the same operation thousands of times a year, throughput and quality both climb — the classic example is the Shouldice hernia hospital. The UK built dedicated surgical hubs on the same logic.

Concentrating routine cases also protects them from being bumped whenever the main hospital fills with emergencies.

Why it worksSpecialisation lifts volume and tends to lower complication rates at once.
The honest riskConcentration creates rural access gaps; needs a referral path for cases too complex for a focused centre.
Difficulty: ModerateTime to impact: 1–3 yrsEvidence: Shouldice · UK hubs
FIX 06

Faster licensing for trained newcomers

Example: a nurse who practised 10 years in Manila waits 2+ years to work here. Streamline the red tape — keep the clinical bar.
Moderate

Thousands of internationally trained clinicians already live here but face slow, fragmented, expensive re-licensing — repeating paperwork, not skills. Streamlining assessment turns latent talent into working clinicians in months, not the decade it takes to train a new graduate.

How quality stays high: the clinical standard doesn't move. Candidates still pass the same national exams and complete supervised practice before independent licensure. What changes is the queue and the duplicated bureaucracy — not the bar they have to clear.

Why it worksAdds real headcount quickly, and improves cultural and linguistic match for diverse communities. Quality is protected by unchanged exams and supervised-practice requirements.
The honest riskStandards must stay rigorous and consistent across provinces; aggressive recruiting from lower-income countries raises ethical questions about draining their workforces.
Difficulty: ModerateTime to impact: 1–2 yrsEvidence: Cross-province reform
FIX 07

Public-funded day-surgery clinics

Independent clinics handle routine surgery and bill the public plan — patients pay nothing.
Heavy lift

Routine procedures — cataracts, scopes, hips — don't need a full acute hospital. Dedicated ambulatory clinics (often non-profit) can do them at high volume while hospitals focus on complex cases.

The public plan pays the clinic at a public rate; the patient is billed nothing. Saskatchewan used exactly this to cut its surgical wait dramatically between 2010 and 2014.

Why it worksProven in-country: Saskatchewan went from worst-in-class to one of the best in ~4 years.
The honest riskIf contracts let clinics re-hire public staff for the same hours, it shifts capacity rather than adding it.
Difficulty: Heavy liftTime to impact: 1–3 yrsEvidence: Saskatchewan · UK ISTCs
FIX 08

Activity-based funding

Pay hospitals for each completed procedure, instead of a fixed annual lump sum.
Heavy lift

Today most Canadian hospitals run on a "global budget" — a fixed pot set at the start of the year. Treating one more patient just spends it faster, so an extra surgery is a cost, not a win. The incentive quietly rewards doing less.

Activity-based funding flips that: the money follows the patient. Each completed, case-mix–adjusted procedure pays a set public price, so an idle Friday operating room becomes revenue left on the table.

Why it worksDirectly rewards throughput; countries that adopted it moved more patients through existing capacity.
The honest riskCan tempt over-treatment, cherry-picking, or upcoding — unless pricing is acuity-weighted and billing is audited.
Difficulty: Heavy liftTime to impact: 3+ yrsEvidence: Australia · Sweden · England

Scope matters: these target high-volume elective backlogs — hips, knees, cataracts, scopes, scans. Complex intensive care, cancer, and emergency care stay on public global budgets — the firewall protecting core public services.

④ The hard questions

The objections — and the honest answers.

Every reform meets resistance — and good ones survive the hardest version of it. So here’s the strongest case against each lever, what we’ll concede, and where we land. We’d rather have this conversation than win an argument.

"This is two-tier medicine. The rich will buy their way to the front."
Fair. Here’s what’s true about that —Queue-jumping by wealth is the deepest fear in Canadian healthcare — and a real risk if delivery is privatised without guardrails. Some unregulated private models have let payment buy speed. The worry is earned.And here’s where we land —Separate who pays from who delivers. In a well-designed model the patient pays nothing — the independent clinic bills the public plan at a public rate, and the queue stays centrally sorted by medical urgency, not net worth. That's closer to how Sweden and Saskatchewan ran it than to a US cash market. The catch: it only stays single-tier if the public payer bans paid line-jumping by law. That rule is the whole ballgame.
"Private or stand-alone clinics will poach staff from public hospitals."
Fair. Here’s what’s true about that —Staffing is genuinely zero-sum in the short run — one labour pool, and a sloppy contract can pull people toward easier hours and hollow out public hospitals. The evidence is mixed, and waving it away is how reforms fail.And here’s where we land —The binding constraint is often idle equipment and restricted hours, not raw headcount — ORs and scanners sit dark on evenings and weekends. Reform that unlocks that off-peak time and pays for finished care can add capacity without a net staff transfer, and contracts can require extra hours, not substitute them. The catch: it needs real workforce monitoring, or the fear becomes self-fulfilling.
"Profit motives don't belong anywhere near a public good."
Fair. Here’s what’s true about that —Money can distort care. Paying per procedure can tempt providers to over-treat, skim easy cases, or game the billing codes. These are documented failure modes abroad and must be designed against.And here’s where we land —That argument is, quietly, already over: family doctors, pharmacies, and labs across Canada are mostly independent operators billing the public plan. Fixed annual budgets actually penalise doing more; outcome-based funding turns each patient back into a reason to act. Guard the failure modes with urgency-weighted pricing, audited billing, and outcome (not just volume) measures.
"A single waiting list takes away my choice of doctor."
Fair. Here’s what’s true about that —Patients value continuity and the ability to choose a trusted surgeon — pooling referrals can feel like losing that.And here’s where we land —Single-entry queues typically keep an opt-out: you can still request a specific surgeon and wait longer, or take the next available one and be seen sooner. The default changes, not your right to choose — and the people who most need speed stop being penalised by it.
"Letting others do more, or fast-tracking newcomers, will lower the standard of care."
Fair. Here’s what’s true about that —Scope and credentialing exist for patient safety. Loosening them carelessly is a real risk, and "we need bodies" is not a quality argument.And here’s where we land —The bar doesn't move — the process does. Expanded scope works within clear protocols and oversight; faster licensing streamlines assessment, not standards. Both are already routine in peer systems without measurable quality loss, and both can be monitored with the same outcome data we'd use everywhere else.
"More scanners and digital front-doors just drive overuse and cost."
Fair. Here’s what’s true about that —Supply can induce demand — more MRI capacity can mean more low-value scans, and digital tools can add clicks without removing work.And here’s where we land —Pair capacity with referral guidelines and decision support so the right patients get imaged faster, while eConsults resolve many questions without a scan at all. The goal is throughput on the cases that matter, not volume for its own sake — which is exactly what the outcome metrics are there to police.

You’ve seen the whole picture

Now go build the version you’d vote for.

Head back to the model, stack your fixes, and share the impact you’d create — or bring us a stuck system of your own.

Sources & verification

Tags: established we’re confident from public reporting · verify reported figure, confirm against the primary document · illustrative our framing/estimate, not a measured statistic.

  1. verifiedMedian total wait, GP referral → treatment: 28.6 weeks (2025), down from 30.0 in 2024 — the second-highest in the survey’s history. Also: 1.39M procedures in queue (3.3% of population); only ~16.5% of patients waiting voluntarily, 40.7% would take a slot within a week; cost of waiting ~$3,364–$10,266/patient/yr; cross-checks suggest the figure may understate real waits. Moir & Esmail, Waiting Your Turn 2025 (Fraser Institute; 34th annual survey, 1,577 physicians, 13.1% response — a survey of physician estimates, not administrative data).
  2. verified9.3-week total median in 1993 (28.6 wks in 2025 is 208% higher): same report, Figures E1/E2.
  3. verifiedAt least 23,746 Canadians died on a waiting list Apr 2024–Mar 2025 (+3% YoY; 100,000+ since 2018); $244B public spend / ~$5,943 per capita; fewer doctors, beds & MRIs per capita than peers. SecondStreet.org, reported by CTV News (Nov 26 2025). Based on FOI to 40+ health bodies; Alberta & parts of Manitoba supplied no data — undercount. Counts deaths on a list, not necessarily caused by waiting.
  4. verifyCanada near the bottom of peers on timely access despite high spend: Commonwealth Fund (Mirror, Mirror) & OECD. Directionally well-supported; exact rankings vary by edition — confirm the latest.
  5. establishedSaskatchewan Surgical Initiative (2010–2014) sharply reduced surgical waits via pooled referrals & contracted day-surgery capacity; Alberta hip/knee single-entry pilots.
  6. establishedActivity-based / case-based hospital funding in Australia, Sweden & England — documented throughput gains and known failure modes (upcoding, volume incentives). See also Hajizadeh & Jalili (ref 9).
  7. verifiedCanada below peers on MRI/CT units per capita (OECD, Health at a Glance); median MRI wait 18.1 weeks and CT 8.8 weeks in 2025, both rising since 2023 (Fraser 2025, Table F1).
  8. illustrativeThe 3%/yr long-run drift, bottleneck percentages, fix “effect sizes,” and the lives estimate are Istari’s transparent model assumptions, calibrated to the direction of the evidence above — not measured coefficients. All editable; see note below.
  9. peer-reviewedEmerging initiatives to cut Canadian wait times: Hajizadeh M, Jalili F. “Addressing healthcare waiting time challenges in Canada: insights from emerging initiatives.” Int J Health Policy Manag. 2025;14:8986. doi:10.34172/ijhpm.8986.

Model assumptions, exposed on purpose — base wait 28.6 wks; an upward “drift” that accelerates over time (a demand-feedback proxy: longer queues beget sicker, more numerous patients), calibrated to the ~3–3.6%/yr the wait has compounded since 1993 (note it dipped modestly in 2025 even as wait-list deaths rose ~3%); reforms that phase in non-linearly with diminishing returns when stacked. Effect sizes reflect the direction of evidence on the reforms above, not measured coefficients. Change them and you change the conclusions; that transparency is the credibility.